/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Lixte Biotechnology Holdings Inc.\n \n\n\n\n\n
Nov 20 6:34 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Jul 02, 2009 9:01 AM EDT
\n\n \n Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models - PR Newswire\n \n \n
\n\n Oct 20, 2008 9:20 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces New Appointment to Board of Directors - PR Newswire\n \n \n
\n\n Aug 19, 2008 8:15 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents - PR Newswire\n \n \n
\n\n Aug 12, 2008 10:18 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases - PR Newswire\n \n \n
\n\n Aug 08, 2008 8:15 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer - PR Newswire\n \n \n
\n\n Jun 25, 2008 10:36 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs - PR Newswire\n \n \n
\n\n Apr 23, 2008 9:01 AM EDT
\n\n \n Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research - PR Newswire\n \n \n
\n
\n\n");